Table 5. Independent predictors of SVR in patients who completed the scheduled 48-week treatment regimen with pegIFNα and ribavirin.

Variables	Odds ratio	95% CI	p
IL28B T vs. G allele	2.61	1.2–5.6	0.01
HCV Genotype 2+3 vs. 1+4	3.61	1.98–6.58	<0.001

SVR: sustained virological response. pegIFNα: pegylated interferon alpha. CI: confidence interval.